+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Hemostat Market - Global Forecast to 2030- Product Image
Topical Hemostat Market - Global Forecast to 2030- Product Image
Sale

Topical Hemostat Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Hemostat Market grew from USD 2.26 billion in 2024 to USD 2.41 billion in 2025. It is expected to continue growing at a CAGR of 6.85%, reaching USD 3.36 billion by 2030.

The topical hemostat sector has emerged as a pivotal component of modern surgical and wound-care protocols, offering clinicians rapid and effective solutions to control bleeding and promote hemostasis. Fueled by continuous innovation in biomaterials and delivery methods, the market responds to growing procedural volumes, rising demand for minimally invasive techniques, and an aging patient population with complex comorbidities. Advanced formulations, including thrombin-based agents and polysaccharide scaffolds, deliver targeted action at the bleeding site, accelerating recovery and reducing complications. Simultaneously, end users from ambulatory surgery centers to home-care settings seek versatile, easy-to-apply products that streamline workflows and enhance patient safety. Regulatory bodies have also introduced more nuanced guidelines, recognizing the critical role of hemostats in reducing transfusion requirements and lowering overall healthcare costs. As supply chains evolve and distribution channels expand, healthcare providers and manufacturers must navigate shifting dynamics to capitalize on emerging opportunities. This executive summary synthesizes transformative shifts, tariff impacts, segmentation and regional nuances, competitive landscapes, and actionable strategies to equip decision-makers with a comprehensive view of the topical hemostat landscape.

Transformative Shifts Reshaping Market Dynamics

The competitive environment has undergone a profound metamorphosis driven by breakthroughs in material science, patient-centric care models and supply-chain resilience strategies. Novel polymer-based matrices and hybrid biologics have displaced traditional collagen sponges, enabling faster clotting and lower immunogenicity. Moreover, integration of digital tracking and barcoding has optimized inventory control, reducing waste and ensuring product traceability across care settings. Regulatory emphasis on value-based outcomes has pushed manufacturers to demonstrate comparative effectiveness through clinical evidence, prompting collaborations between industry leaders and academic research centers. Concurrently, the rise of minimally invasive and ambulatory procedures has expanded the addressable market beyond hospital operating rooms to freestanding surgical centers and even home-care scenarios. Trade-policy shifts and raw-material constraints have prompted strategic reshoring and diversification of supply bases, enhancing resilience without compromising quality. These converging trends have not only intensified competition but also elevated product differentiation, as companies vie to deliver next-generation hemostatic solutions that align with evolving clinical protocols and economic imperatives.

Cumulative Impact of United States Tariffs 2025

In 2025, newly imposed tariffs on hemostatic agents and their raw-material inputs have reverberated across the supply chain, altering cost structures and strategic priorities. Manufacturers reliant on imported polymers and recombinant thrombin have experienced margin compression, leading some to negotiate long-term contracts with domestic suppliers or to vertically integrate key processes. Healthcare providers, facing higher unit costs, have accelerated value-analysis initiatives to identify cost-effective alternatives or to renegotiate procurement agreements. Concurrently, distributors have reevaluated their logistics models, consolidating shipments and optimizing warehouse footprints to absorb tariff-related expenses. As a result, certain niche players have expanded their footprint by emphasizing locally produced formulations, while larger corporations have leveraged scale to mitigate price increases. These adaptive measures underscore the market’s resilience, but also highlight the necessity for transparent cost pass-through mechanisms and strategic sourcing frameworks to sustain accessibility and innovation.

Key Segmentation Insights

Segmenting the topical hemostat market reveals a multi-layered framework that guides product development and go-to-market strategies. When analyzed by product type, offerings divide into Active Hemostats, Combination Hemostats and Passive Hemostats: Active variants further distinguish between Combination Products and Thrombin-Based formulations, whereas Combination Hemostats encompass Fibrin-Based and Polysaccharide-Based systems. Passive Hemostats include Collagen-Based, Gelatin-Based and Oxidized Regenerated Cellulose materials. Application-focused segmentation highlights Dental Applications, Surgical Applications and Wound Care: dental uses concentrate on oral surgeries, while surgical procedures span cardiovascular, gynecological, neurosurgery and orthopedic specialties. By end user, the market serves Ambulatory Surgical Centers, Home Care Settings and Hospitals: ambulatory centers split into freestanding surgery centers and hospital-connected facilities, and hospitals differentiate between private and public institutions. Material types stand apart as Chitosan-Based or Microfibrillar Collagen. Mode of Use breaks down into Adhesive Paste, Film and Topical Powder formats, and Distribution Channels range from Direct Purchase to Distributor Sales. Finally, Technology segmentation contrasts Gel-Based and Lyophilized processes. This granular segmentation illuminates growth pockets and informs targeted innovations.

Key Regional Insights

Regional variations in adoption, reimbursement and clinical practice drive divergent growth trajectories across the Americas, Europe, Middle East & Africa and Asia-Pacific. In the Americas, strong reimbursement frameworks and high procedural volumes have spurred rapid uptake of advanced hemostatic agents, particularly in cardiovascular and orthopedic settings. Europe, Middle East & Africa benefit from harmonized regulatory pathways in the EU, fostering collaboration among local manufacturers and academic centers, while emerging markets in the Middle East deploy cost-efficient collagen-based products. Asia-Pacific exhibits robust medical infrastructure expansion, with increasing investments in minimally invasive surgery driving demand for both lyophilized thrombin agents and gel-based systems. Yet, price sensitivity and varied reimbursement models in certain APAC markets necessitate tiered product portfolios. Across all regions, strategic partnerships between global players and regional distributors are vital for overcoming regulatory complexities and logistics challenges, ensuring timely product availability and localized support.

Key Companies Insights

The competitive arena includes a diverse set of established multinationals and specialized innovators. Aegis Lifesciences Private Limited emphasizes indigenous R&D to tailor chitosan-based dressings for emerging markets, while Axio Biosolutions Pvt Ltd focuses on novel thrombin preparations. B.Braun Melsungen AG and Baxter International, Inc. leverage broad portfolios spanning active and passive hemostats, integrating value-based contracting models. Becton, Dickinson and Company and Medline Industries, LP deliver robust distribution networks, whereas Betatech Medical and Hemostasis, LLC carve niches in collagen-based sponges. BioCer Entwicklungs-GmbH and GELITA MEDICAL GmbH pioneer polysaccharide scaffolds. Global giants such as Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Pfizer Inc. and Takeda Pharmaceutical Company Limited extend their presence through strategic alliances and acquisitions. Dilon Technologies Inc and Medtrade Products Ltd introduce innovative delivery formats, while Integra LifeSciences Corporation and Stryker Corporation integrate hemostats into surgical system bundles. Marine Polymer Technologies, Inc., Meril Life Sciences Pvt. Ltd, Southmedic Inc., SYMATESE SAS, Teleflex Incorporated, Zeria Pharmaceutical Co., Ltd. and Medtronic PLC further enrich the landscape with differentiated formulations and strong regional footholds.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multipronged approach to maintain competitive advantage. First, forging strategic partnerships with raw-material suppliers and research institutes will secure access to cutting-edge biomaterials and minimize exposure to tariff fluctuations. Second, diversifying revenue streams by expanding into emerging end-user settings-such as home-care wound-management programs and ambulatory surgery centers-will capture untapped demand. Third, investing in modular production platforms and digital batch-tracking systems will bolster supply-chain agility and regulatory compliance. Fourth, aligning product portfolios with regional reimbursement nuances-offering premium lyophilized agents in mature markets and cost-effective collagen-based options in price-sensitive regions-will optimize market penetration. Finally, pursuing targeted acquisitions of innovative start-ups or co-development deals will accelerate entry into specialized segments like neurosurgical hemostasis and polysaccharide-derived scaffolds. Collectively, these measures will strengthen resilience, foster sustainable growth and enhance value delivery across the topical hemostat ecosystem.

Conclusion

The topical hemostat market stands at an inflection point, shaped by breakthroughs in biomaterial engineering, shifting policy landscapes and evolving clinical practices. As manufacturers and providers confront tariff-induced cost pressures and intensifying competitive dynamics, they must leverage granular segmentation, regional insights and strategic alliances to navigate complexity. By embracing innovative technologies, aligning with value-based care imperatives and fortifying supply chains, stakeholders can drive product differentiation and operational efficiency. The road ahead demands agile decision-making and a commitment to evidence-based outcomes, ensuring that hemostatic solutions continue to elevate patient care and deliver measurable benefits.

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Active Hemostats
    • Combination Products
    • Thrombin-Based
  • Combination Hemostats
    • Fibrin-Based
    • Polysaccharide-Based
  • Passive Hemostats
    • Collagen-Based
    • Gelatin-Based
    • Oxidized Regenerated Cellulose
  • Dental Applications
    • Oral Surgeries
  • Surgical Applications
    • Cardiovascular Surgery
    • Gynecological Surgery
    • Neurosurgery
    • Orthopedic Surgery
  • Wound Care
  • Ambulatory Surgical Centers
    • Freestanding Surgery Centers
    • Hospital-Connected Surgery Centers
  • Home Care Settings
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Chitosan-Based
  • Microfibrillar Collagen
  • Adhesive Paste
  • Film
  • Topical Powder
  • Direct Purchase
  • Distributor Sales
  • Gel Based
  • Lyophilized

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Topical Hemostat Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Hemostat Market, by Product Type
8.1. Introduction
8.2. Active Hemostats
8.2.1. Combination Products
8.2.2. Thrombin-Based
8.3. Combination Hemostats
8.3.1. Fibrin-Based
8.3.2. Polysaccharide-Based
8.4. Passive Hemostats
8.4.1. Collagen-Based
8.4.2. Gelatin-Based
8.4.3. Oxidized Regenerated Cellulose
9. Topical Hemostat Market, by Application
9.1. Introduction
9.2. Dental Applications
9.2.1. Oral Surgeries
9.3. Surgical Applications
9.3.1. Cardiovascular Surgery
9.3.2. Gynecological Surgery
9.3.3. Neurosurgery
9.3.4. Orthopedic Surgery
9.4. Wound Care
10. Topical Hemostat Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Freestanding Surgery Centers
10.2.2. Hospital-Connected Surgery Centers
10.3. Home Care Settings
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Topical Hemostat Market, by Material Type
11.1. Introduction
11.2. Chitosan-Based
11.3. Microfibrillar Collagen
12. Topical Hemostat Market, by Mode of Use
12.1. Introduction
12.2. Adhesive Paste
12.3. Film
12.4. Topical Powder
13. Topical Hemostat Market, by Distribution Channel
13.1. Introduction
13.2. Direct Purchase
13.3. Distributor Sales
14. Topical Hemostat Market, by Technology
14.1. Introduction
14.2. Gel Based
14.3. Lyophilized
15. Americas Topical Hemostat Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Topical Hemostat Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Topical Hemostat Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Aegis Lifesciences Private Limited
18.3.2. Axio Biosolutions Pvt Ltd
18.3.3. B.Braun Melsungen AG
18.3.4. Baxter International, Inc.
18.3.5. Becton, Dickinson and Company
18.3.6. Betatech Medical
18.3.7. BioCer Entwicklungs-GmbH
18.3.8. Bristol-Myers Squibb Company
18.3.9. Dilon Technologies Inc
18.3.10. GELITA MEDICAL GmbH
18.3.11. Hemostasis, LLC
18.3.12. Integra LifeSciences Corporation
18.3.13. Johnson & Johnson Services, Inc.
18.3.14. Marine Polymer Technologies, Inc.
18.3.15. Medline Industries, LP
18.3.16. Medtrade Products Ltd
18.3.17. Medtronic PLC
18.3.18. Meril Life Sciences Pvt. Ltd
18.3.19. Pfizer Inc.
18.3.20. Southmedic Inc.
18.3.21. Stryker Corporation
18.3.22. SYMATESE SAS
18.3.23. Takeda Pharmaceutical Company Limited
18.3.24. Teleflex Incorporated
18.3.25. Zeria Pharmaceutical Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. TOPICAL HEMOSTAT MARKET MULTI-CURRENCY
FIGURE 2. TOPICAL HEMOSTAT MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POLYSACCHARIDE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FREESTANDING SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL-CONNECTED SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CHITOSAN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MICROFIBRILLAR COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ADHESIVE PASTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TOPICAL POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GEL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 99. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 100. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 101. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 103. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 106. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 109. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 171. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 172. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 173. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 175. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 178. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 180. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 181. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 185. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 186. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 187. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 189. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 192. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 195. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 214. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 215. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 290. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 292. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 293. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 297. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 298. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 299. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 301. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 304. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 306. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 307. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MODE OF USE, 2018-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 338. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 340. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 341. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PASSIVE HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 342. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)

Companies Mentioned

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032 - Product Image

Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032

  • Report
  • 277 Pages
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Hemostats Market Report 2025 - Product Image

Hemostats Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From

About the Topical Hemostat Market

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.